Regeneron Pharmaceuticals traded at $692.57 this Friday May 27th, increasing $9.13 or 1.34 percent since the previous trading session. Looking back, over the last four weeks, Regeneron Pharmaceuticals gained 2.51 percent. Over the last 12 months, its price rose by 37.84 percent. Looking ahead, we forecast Regeneron Pharmaceuticals to be priced at 645.31 by the end of this quarter and at 598.66 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
692.57
Daily Change
1.34%
Yearly
37.84%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Kyowa Hakko Kirin 2,711.00 36.00 1.35% -18.10%
Astellas Pharma 2,025.50 -10.50 -0.52% 16.14%
AbbVie 150.01 -0.56 -0.37% 32.52%
Agenus 1.57 0.07 4.67% -63.15%
Agios Pharmaceuticals 19.67 0.28 1.44% -64.74%
Alimera Sciences 5.78 -0.02 -0.34% -44.95%
Alnylam Pharmaceuticals 124.16 -1.44 -1.15% -12.56%
Amgen 255.19 2.14 0.84% 7.25%
AstraZeneca 10,474.00 -72.00 -0.68% 30.18%
Biogen 206.06 1.84 0.90% -22.96%
Bluebird Bio 3.23 0.07 2.06% -89.64%
BioMarin Pharmaceutical 80.83 1.97 2.50% 4.57%
Bristol-Myers Squibb 76.14 -1.45 -1.87% 15.86%
Esperion Therapeutics 5.46 -0.05 -0.91% -72.97%
Gilead Sciences 64.76 0.29 0.45% -2.04%
GlaxoSmithKline 1,738.00 -15.80 -0.90% 29.30%
Intercept Pharmaceuticals 17.33 -0.07 -0.40% 1.46%
Incyte Corp 77.17 1.15 1.51% -7.89%
Ionis Pharmaceuticals 36.71 0.06 0.16% -0.38%
J&J 181.11 1.65 0.92% 7.01%
Eli Lilly 323.51 10.05 3.21% 61.97%
Merck & Co 93.09 0.79 0.86% 22.66%
Moderna Inc 147.65 11.85 8.73% -20.19%
Neurocrine Biosciences 90.54 0.70 0.78% -6.80%
Novartis 86.92 -0.90 -1.02% 8.66%
Novartis 90.88 -0.38 -0.42% 2.71%
Iveric bio Inc. 10.70 -0.14 -1.29% 51.99%
Opthea Ltd 1.33 0.02 1.14% -10.74%
Puma Biotechnology 1.96 0 0% -81.63%
Pfizer 53.89 -0.10 -0.19% 39.14%
Ultragenyx Pharmaceutical 45.93 0.09 0.19% -55.65%
Regeneron Pharmaceuticals 692.57 9.13 1.34% 37.84%
Roche Holding 328.20 -4.80 -1.44% 4.79%
Seattle Genetics 138.99 0.53 0.38% -8.01%
Sanofi 55.06 -0.44 -0.79% 3.97%
Sarepta Therapeutics 72.59 1.69 2.38% -5.56%
Teva Pharmaceutical Industries Ltd 2,979.00 69.00 2.37% -13.58%
United Therapeutics 226.83 2.05 0.91% 22.02%
Vertex Pharmaceuticals 273.80 4.15 1.54% 31.24%

Indexes Price Day Year
US500 4158 100.40 2.47% -1.09%
USND 12131 390.48 3.33% -11.77%
USNDX 12681 404.63 3.30% -7.34%

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious diseases. The Company commercializes medicines and product candidates for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases, and rare diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Dupixent (dupilumab) Injection, Libtayo (cemiplimab) Injection, Praluent (alirocumab) Injection, Kevzara (sarilumab) Solution for Subcutaneous Injection, Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion.